Tenet Healthcare (THC) closed at $286.46 on November 5, 2026, down 2.0% from the previous close, on volume of 991,285 shares (30-day average 707,714).
Data as of November 5, 2026.
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Thu, 5-Nov 6:10 PM ET)
Blue wave lifts hospital stocks, health insurers
Seeking Alpha News (Wed, 4-Nov 12:50 PM ET)
Barclays Remains a Buy on Tenet Healthcare (THC)
TipRanks (Wed, 4-Nov 3:58 AM ET)
Leerink Partners Keeps Their Buy Rating on Tenet Healthcare (THC)
TipRanks (Mon, 2-Nov 11:42 AM ET)
Tenet Healthcare (THC) Receives a Buy from UBS
TipRanks (Mon, 2-Nov 11:39 AM ET)
Tenet Healthcare (THC) Gets a Buy from RBC Capital
TipRanks (Mon, 2-Nov 10:29 AM ET)
Tenet Healthcare Earnings Call Signals Stronger Growth Ahead
TipRanks (Sun, 1-Nov 7:19 PM ET)
Tenet raises 2026 outlook after $1.36 billion Q3 adjusted EBITDA and $6.64 adjusted EPS
Market Chameleon (Thu, 29-Oct 5:17 AM ET)
Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook
Business Wire (Thu, 29-Oct 6:45 AM ET)
Tenet to Report Its Third Quarter 2026 Results on October 29
Business Wire (Fri, 2-Oct 8:00 AM ET)
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Tenet Healthcare trades on the NYSE stock market under the symbol THC.
As of November 5, 2026, THC stock price declined to $286.46 with 991,285 million shares trading.
THC has a beta of 0.69, meaning it tends to be less sensitive to market movements. THC has a correlation of 0.04 to the broad based SPY ETF.
THC has a market cap of $22.80 billion. This is considered a Large Cap stock.
Last quarter Tenet Healthcare reported $6 billion in Revenue and $6.64 earnings per share. This beat revenue expectation by $129 million and exceeded earnings estimates by $1.98.
In the last 3 years, THC traded as high as $301.44 and as low as $52.08.
The top ETF exchange traded funds that THC belongs to (by Net Assets): IJH, VTI, VB, VBR, VFLO.
THC has outperformed the market in the last year with a price return of +37.9% while the SPY ETF gained +9.7%. THC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +13.1% and +6.4%, respectively, while the SPY returned -4.7% and -5.2%, respectively.
THC support price is $285.01 and resistance is $299.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THC shares will trade within this expected range on the day.